When Bud Cauley’s car crashed in 2018, the damage was catastrophic. Six broken ribs. A collapsed lung. A fractured leg. Surgeons went in with brackets and essentially rebuilt his entire rib cage. For ...

Sutro Biopharma is an early-stage ADC developer, trading at a $406m market cap after a strong 6-month rally. Click to read my latest analysis of STRO stock.

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...